Exacerbation of invasive aspergillosis by the immunosuppressive fungal metabolite, gliotoxin

Immunology and Cell Biology

Volumn 74, Issue 4, 1996, Pages 318-322

  Sutton, Philip ^a   Waring, Paul ^a   Müllbacher, Arno ^a  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

Aspergillosis; Aspergillus fumigatus; Gliotoxin; Immunosuppression

Indexed keywords

GLIOTOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CONTROLLED STUDY; FEMALE; IMMUNOMODULATION; MOUSE; NONHUMAN;

ANIMALIA; ASPERGILLUS FUMIGATUS;

EID: 0029764905     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1038/icb.1996.57     Document Type: Article

References (23)

1. Kusne S, Torre-Ciserno J, Manez R. Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation. J. Infect. Dis. 1992; 166: 1379.
2. Bodey G, Bueltmann B, Duguid W. Fungal infections in cancer patients: an international survey. Eur. J. Clin. Microbiol. Infect. Dis. 1992; 11: 99.
3. Eichner RD, Salaami A, Wood PR, Müllbacher A. The effect of gliotoxin upon macrophage function. Int. J. Immunopharmac. 1986; 8: 789.
4. Müllbacher A, Eichner RD. Immunosuppression in vitro by a metabolite of a human pathogenic fungus. Proc. Natl Acad. Sci. USA 1984; 81: 3835.
5. Müllbacher A, Waring P, Tiwari-Palni U, Eichner RD. Structural relationship of epipolythiodioxopiperazines and their immunomodulating activity. Mol. Immunol. 1986; 23: 231.
6. Sutton P, Newcombe NR, Waring P, Müllbacher A. In vivo immunosuppressive activity of gliotoxin, a metabolite produced by human pathogenic fungi. Infect. Immunity 1994; 62: 1192.
7. Müllbacher A, Moreland AF, Waring P, Sjaarda A, Eichner RD. Prevention of graft versus host disease by treatment of bone marrow with gliotoxin in fully allogeneic chimeras and their cytotoxic T cell repertoire. Transplantation 1988; 46: 120.
8. Sutton P, Waring P, Müllbacher A. Investigation of the potential use of the immunosuppressive agent, gliotoxin, in organ transplantation. Transplantation. 1995; 60: 900.
9. Eichner RD, Waring P, Geue AM, Braithwaite AW, Müllbacher A. Gliotoxin causes oxidative damage to plasmid and cellular DNA. J. Biol. Chem. 1988; 263: 3772.
10. Waring P. DNA fragmentation induced in macrophages by gliotoxin does not require synthesis and is preceded by raised inositol triphosphate levels. J. Biol. Chem. 1990; 265: 14476.
11. Sutton P, Beaver J, Waring P. Evidence that gliotoxin en hances lymphocyte activation and induces apoptosis by effects on cyclic AMP levels. Biochem. Pharmacol. 1995; 50: 2009.
12. Waring P, Eichner RD, Müllbacher A, Sjaarda A. Gliotoxin induced apoptosis in macrophages unrelated to its antiphagocytic properties. J. Biol. Chem. 1988; 263: 18493.
13. Stanley NF, Mills JA. The biological activity of a substance resembling gliotoxin produced by a strain of Aspergillus fumigatus. Aust. J. Exp. Biol. Med. Sci. 1946; 24: 133.
14. Shah DT, Larsen B. Clinical isolates of yeast produce a gliotoxin-like substance. Mycopathologia 1991; 116: 203.
15. Eichner RD, Waring P, Tiwari-Palni U, Müllbacher A. Identification of possible cofactors in AIDS. AIDS Res. 1987; 2: 157.
16. Eichner RD, Müllbacher A. Fungal toxins are involved in Aspergillosis and AIDS. Aust. J. Exp. Biol. Med. Sci. 1984; 62: 479.
17. Müllbacher A, Waring P, Eichner RD. Identification of an agent in cultures of Aspergillus fumigatus displaying antiphagocytic and immunomodulating activity in vitro. J. Gen. Microbiol. 1985; 131: 1251.
18. Darzynkiewicz Z, Bruno S, Del Bino G et al. Features of apoptotic cells measured by flow cytometry. Cytometry 1992; 13: 795.
19. Jordan TW, Cordiner SJ. Fungal epipolythiodioxopiperazine toxins have therapeutic potential and roles in disease. TIPS 1987; 8: 144.
20. Sidransky H, Epstein SM, Verney E, Horowitz C. Experimental visceral aspergillosis. Am. J. Pathol. 1972; 69: 55.
21. Tang CM, Cohen J, Krausz T, Noorden SV, Holden DW. The alkaline protease of Aspergillus fumigatus is not a virulence determinant in two murine models of invasive pulmonary aspergillosis. Infect. Immun. 1993; 61: 1650.
22. Schaffner A, Douglas H, Braude A. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to aspergillus. J. Clin. Invest. 1982; 69: 617.
23. Repentigny LD, Petitbois S, Boushira M et al. Acquired immunity in experimental murine aspergillosis is mediated by macrophages. Infect. Immun. 1993; 61: 3791.